OrganiGram 2Q Loss Widens

Dow Jones05-14
 

By Adriano Marchese

 

OrganiGram Holdings on Tuesday reported a wider loss in its second fiscal quarter on the back of fair-value changes on its balance sheet in the quarter.

For the three months ended March 31, the Canadian licensed cannabis producer posted a widened loss of $27.1 million, compared with $7.5 million in the comparable quarter a year ago.

The wider loss was largely due to lower unrealized gain on changes in the fair value of biological assets and of derivative liabilities of $12.5 million

OrganiGram also posted an adjusted loss before earnings, taxes, depreciation and amortization of $1 million, compared with a profit of $5.6 million.

Revenue fell by 5% to $37.6 million, in-line with analyst expectations for the period, according to FactSet.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

May 14, 2024 06:53 ET (10:53 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment